SAB Biotherapeutics, Inc. (SABS)
4.40
-0.19
(-4.14%)
USD |
NASDAQ |
Mar 13, 12:06
SAB Biotherapeutics EPS Diluted (Quarterly) : -0.8134 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acumen Pharmaceuticals, Inc. | -0.4367 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.845M |
| Total Expenses (Quarterly) | 2.845M |
| Enterprise Value | 127.87M |
| Earnings Yield | -60.76% |
| Normalized Earnings Yield | -80.42 |